Lilly's Lechleiter sees pharma clouds abroad

Eli Lilly ($LLY) CEO John Lechleiter (photo) says price squeezes in Europe and Japan will be key challenges to his company's sales in 2012, one week after the company predicted a bigger-than-expected decline in profits this year. Report